South Sudan

COVID-19 Update for South Sudan - 20 January 2022


COVID-19 Overview

  • 53.2% decrease in cases from the week ending 16 January 2022 compared to the preceding week.

  • Partial lockdown extended until end January 2022 to sustain downward trend in cases

  • COVID-19 National Task Force (NTF) adopted recommendation on mandatory testing of in-bound travellers in line with MOH guidelines (only symptomatic travellers to be tested with antigen rapid tests despite having negative PCR test result with 72-hour validity)

  • NO BOOSTER POLICY for South Sudan: Priority is to increase COVID-19 vaccination coverage of population over 18 up to at least 40%.

  • Single dose Johnson & Johnson is preferred vaccine for South Sudan, with Astra Zeneca the second option.
    No other vaccine types are considered for the time being.